Curesponse

Personalized Medicine for Accurate Cancer Treatment

Active A Startup Rehovot Founded 2017-11

Website ↗ LinkedIn

Curesponse’s technology represents the next step in personalized cancer medicine, advancing prediction capabilities beyond genomics to understand how cancer treatments will affect the patient’s tumor cells when they are in their native tumor. The company developed cResponse, a test combined Genomic-Functional assay. The test starts with genomic profiling of…